使用Amplatzer封堵器经导管闭合先天性/后天性肌部室间隔缺损和膜周部室间隔缺损。
Catheter closure of congenital/acquired muscular VSDs and perimembranous VSDs using the Amplatzer devices.
作者信息
Thanopoulos Basil D, Karanassios Evangelos, Tsaousis George, Papadopoulos George S, Stefanadis Christodoulos
机构信息
Department of Pediatric Cardiology, Aghia Sophia Children's Hospital, 1 Thivon and Levadias Street, Athens 11527, Greece.
出版信息
J Interv Cardiol. 2003 Oct;16(5):399-407. doi: 10.1046/j.1540-8183.2003.01007.x.
Over the past 10 years a variety of occluding devices has been used for transcatheter closure of ventricular septal defects (VSDs), but none has gained wide acceptance. This article presents the experience of transcatheter closure of muscular and perimembranous VSDs in 22 and 13 patients, respectively, with the new Amplatzer VSD occluders. Overall total occlusion was achieved in 95% and 92.3% of patients with muscular and perimembranous VSDs, respectively. The main complication was embolization of the device in 1/13 (7.6%) patients with perimembranous VSDs. Transcatheter closure of VSDs using the Amplatzer VSD occluders appears to be a safe and effective alternative to the standard surgical treatment.
在过去10年里，多种封堵装置已被用于经导管关闭室间隔缺损（VSD），但无一获得广泛认可。本文介绍了分别使用新型Amplatzer室间隔缺损封堵器对22例肌部室间隔缺损和13例膜周部室间隔缺损患者进行经导管封堵的经验。总体而言，肌部室间隔缺损和膜周部室间隔缺损患者分别有95%和92.3%实现了完全封堵。主要并发症是1/13（7.6%）例膜周部室间隔缺损患者发生封堵器栓塞。使用Amplatzer室间隔缺损封堵器经导管关闭室间隔缺损似乎是标准外科治疗的一种安全有效的替代方法。
Zotero 插件